Xanthine oxidase-mediated oxidative stress promotes cancer cell-specific apoptosis

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Alternol, a natural compound, exhibits preferential cytotoxicity towards cancer cells.
• Oxidative stress and apoptosis are key mechanisms in Alternol's anti-cancer effects.
• The precise source of reactive oxygen species (ROS) driving Alternol-induced apoptosis remained unclear.

Purpose of the Study:

• To elucidate the specific mechanism of ROS generation induced by Alternol.
• To identify the molecular targets responsible for Alternol's pro-oxidant and apoptotic effects in cancer cells.
• To investigate the role of xanthine dehydrogenase (XDH) in Alternol-mediated cell death.

Main Methods:

• Cell-based assays measuring ROS production, mitochondrial superoxide formation, and cell viability.
• Inhibition studies using specific chemical inhibitors and gene silencing for NOX, NOS, and XDH/XO.
• Analysis of protein oxidation and antioxidant enzyme activity (SOD, catalase).
• In silico molecular docking and protein-ligand interaction studies.

Main Results:

• Alternol moderately increased mitochondrial superoxide but significantly elevated overall ROS levels.
• Inhibition of XDH/XO, but not NOX or NOS, reduced ROS accumulation and protected cells from apoptosis.
• Alternol treatment enhanced XDH oxidative activity and induced protein damage in malignant cells.
• Benign cells showed increased SOD and catalase activity in response to Alternol.
• Alternol directly interacts with the catalytic domain of XDH.

Conclusions:

• Alternol induces cancer cell apoptosis primarily by enhancing XDH oxidative activity, leading to ROS accumulation.
• XDH is a key molecular target mediating the anti-cancer effects of Alternol.
• The findings highlight XDH as a potential therapeutic target for cancer treatment.